Events

MSCA Radiance Online event for MSCA Postdoctoral Fellowships opportunities in Widening Countries
APR
Mon
27
09:30 - 11:00

This was 2 weeks ago

Location

Online

Programmes
MSCA Widening/Spreading

This MSCA Radiance webinar is dedicated to researchers planning to apply for the MSCA Postdoctoral Fellowships with a Widening Country.
This session will include:

Information on Widening Countries is available on the European Commission Research Executive Agency website here.

All information related to this webinar, including the registration form and full agenda, is available in the announcement on the Horizon Europe NCP Portal website.

Agenda in brief (CET)

9.30 Welcome and introduction

9.35 PF highlights

9.45 Presentation of opportunities in Malta

9.55 Presentation of opportunities in Poland

10.05 Presentation of opportunities in Estonia

10.15 Presentation of opportunities in Lithuania

10.25 Presentation of opportunities in Bulgaria

10.35 Questions and answers

11.00 End of event

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.